HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

4 hedge funds and large institutions have $377K invested in Hepion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$278K
2 +$46K
3 +$9K

Top Sellers

1 -$44K
2 -$43K
3 -$39.1K
4
Barclays
Barclays
United Kingdom
-$3K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$278K
2
$46K
3
$44K
4
$9K
5
6
7
8